What is ace inhibitor
Pro Research Analysisby 
Searched over 200M research papers
Understanding ACE Inhibitors: Mechanisms, Benefits, and Developments
Introduction to ACE Inhibitors
Angiotensin-converting enzyme (ACE) inhibitors are a class of medications primarily used to treat cardiovascular and renal diseases. They work by inhibiting the enzyme ACE, which plays a crucial role in the renin-angiotensin system (RAS) that regulates blood pressure and fluid balance 13. By blocking ACE, these inhibitors reduce the production of angiotensin II, a peptide that causes blood vessels to constrict, thereby lowering blood pressure and decreasing the workload on the heart 13.
Mechanisms of Action
Inhibition of Angiotensin II and Bradykinin Modulation
ACE inhibitors decrease the formation of angiotensin II and increase the levels of bradykinin, a vasodilatory peptide. This dual action results in the relaxation of blood vessels, reduced blood volume, and lower blood pressure 13. Additionally, ACE inhibitors promote natriuresis, which is the excretion of sodium in the urine, further aiding in blood pressure control .
Impact on Vasoactive Substances
ACE is a promiscuous enzyme that affects the metabolism of various vasoactive substances. By inhibiting ACE, these medications not only reduce angiotensin II levels but also alter the metabolism of other peptides, contributing to their overall cardiovascular benefits .
Clinical Benefits
Cardiovascular and Renal Protection
ACE inhibitors are effective in treating hypertension, reducing mortality in congestive heart failure, and improving outcomes after myocardial infarction by stabilizing plaques and preventing ischemic events 14. They also delay the progression of diabetic nephropathy and neuropathy, making them valuable in managing diabetes-related complications 12.
Antioxidant and Anti-inflammatory Properties
Some ACE inhibitors possess antioxidant properties, which can be beneficial in treating hypertension and other cardiovascular conditions . These properties help in reducing oxidative stress and inflammation, further protecting the cardiovascular system .
Advances in ACE Inhibitor Development
Domain-Selective Inhibitors
Recent research has focused on developing ACE inhibitors that selectively target the N- and C-domains of the enzyme. This selectivity aims to reduce adverse effects and improve the efficacy of these medications 68. Structural studies of ACE have provided insights into the active site interactions, facilitating the design of more potent and selective inhibitors .
Natural ACE Inhibitors
There is growing interest in natural ACE inhibitors derived from plants and food sources. These natural compounds often have fewer side effects and lower toxicity compared to synthetic drugs 2910. Various plant species and food-derived peptides have shown significant ACE-inhibitory activity, offering potential alternatives for managing hypertension and diabetes-related complications 2910.
Conclusion
ACE inhibitors are a cornerstone in the treatment of cardiovascular and renal diseases due to their ability to modulate key peptides involved in blood pressure regulation. Ongoing research and development are enhancing their efficacy and safety, with promising advances in domain-selective inhibitors and natural ACE inhibitors. These developments hold the potential to provide more effective and safer therapeutic options for patients.
Sources and full results
Most relevant research papers on this topic